Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 7/20 | 0.57 |
| ▸ | REN | P00797 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | LTA4H | P09960 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | PEPD | P12955 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | HTR2A | P28223 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | HRH1 | P35367 | 1/20 | 0.57 |
| ▸ | THPO | P40225 | 1/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.57 |
| ▸ | DPP4 | P27487 | 3/20 | 0.53 |
| ▸ | FAP | Q12884 | 2/20 | 0.53 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31401996 | 1.00 | ACE (0.57) | ACERENKDM4EF2LMNA | |
| SCHEMBL10653331 | 1.00 | ACE (0.57) | ACERENKDM4EF2LMNA | |
| SCHEMBL10829256 | 1.00 | ACE (0.57) | ACERENKDM4EF2LMNA | |
| SCHEMBL31401997 | 1.00 | ACE (0.57) | ACERENKDM4EF2LMNA | |
| SCHEMBL30139015 | 1.00 | ACE (0.57) | ACERENKDM4EF2LMNA | |
| SCHEMBL593691 | 0.94 | ACE (0.64) | ACERENKDM4EF2LMNA | |
| SCHEMBL8316371 | 0.94 | ACE (0.64) | ACERENKDM4EF2LMNA | |
| SCHEMBL2115246 | 0.94 | ACE (0.64) | ACERENKDM4EF2LMNA | |
| SCHEMBL9164453 | 0.94 | ACE (0.64) | ACERENKDM4EF2LMNA | |
| SCHEMBL2115244 | 0.94 | ACE (0.64) | ACERENKDM4EF2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4302 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031713-A | Preparation method and application of linker medicine and antibody-medicine conjugate thereof | 乐普生物科技股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-12622948-B2 | GLP-1/GIP dual agonists | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2026-05-12 | — | — | US | claimed |
| US-20240424063-A1 | LONG ACTING GLP-1/GIP DUAL AGONISTS | SUN PHARMACEUTICAL IND LTD (IN) | 2024-12-26 | — | — | US | claimed |
| US-20240400613-A1 | GLP-1/GIP DUAL AGONISTS | SUN PHARMACEUTICAL IND LTD (IN) | 2024-12-05 | — | — | US | claimed |
| WO-2024160176-A1 | LINKER DRUG, AND PREPARATION METHOD AND USE OF ANTIBODY-DRUG CONJUGATE THEREOF | 上海美雅珂生物技术有限责任公司 | 2024-08-08 | — | — | WO | claimed |
| US-20230241178-A1 | LONG ACTING GLP-1/GIP DUAL AGONISTS | SUN PHARMACEUTICAL IND LTD (IN) | 2023-08-03 | — | — | US | claimed |
| EP-4204440-A1 | GLP-1/GIP DUAL AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2023-07-05 | — | — | EP | claimed |
| CN-116171164-A | GLP-1/GIP dual agonists | 太阳医药工业有限公司 | 2023-05-26 | — | — | CN | claimed |
| EP-4146248-A1 | LONG ACTING GLP-1/GIP DUAL AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2023-03-15 | — | — | EP | claimed |
| CN-115768460-A | Long-acting GLP-1/GIP dual agonists | 太阳医药工业有限公司 | 2023-03-07 | — | — | CN | claimed |
| US-20220313770-A1 | IMMUNOTHERAPY FOR ANGIOGENIC DISEASE | INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC. (JP) | 2022-10-06 | — | — | US | claimed |
| CN-114949171-A | Immunotherapy of angiogenic diseases | 株式会社癌免疫研究所 | 2022-08-30 | — | — | CN | claimed |
| US-11413322-B2 | Immunotherapy for angiogenic disease | INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC. (JP) | 2022-08-16 | — | — | US | claimed |
| US-11369656-B2 | Immunotherapy for angiogenic disease | INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC. (JP) | 2022-06-28 | — | — | US | claimed |
| CN-108064163-B | Immunotherapy of angiogenic diseases | 株式会社癌免疫研究所 | 2022-06-10 | — | — | CN | claimed |
| WO-2022079639-A1 | GLP-1/GIP DUAL AGONISTS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2022-04-21 | — | — | WO | claimed |
| JP-61053298-A | — | — | None | — | — | JP | disclosed |
| CN-122075733-A | Preparation method and application of linker medicine and antibody-medicine conjugate thereof | — | 2026-05-26 | — | — | CN | disclosed |
| JP-S6153298-A | AMINO ACID DERIVATIVE AND HYPOTENSOR CONTAINING SAME | AJINOMOTO CO INC | 1986-03-17 | — | — | JP | disclosed |
| EP-0173510-A2 | Tripeptide derivatives for use as anti-hypertensive agents | AJINOMOTO CO., INC. (JP) | 1986-03-05 | — | — | EP | disclosed |